← All trials
NCT05191797
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 11, 2022
- Primary completion
- Jan 15, 2025
- Completion date
- Jan 15, 2026
- First posted
- Jan 14, 2022
- Last posted
- Jun 24, 2022
- Enrollment
- 34
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of WashingtonLead sponsor
- Imago BioSciencesCollaborator
- National Cancer Institute (NCI)Collaborator
- University of WashingtonOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.